Swaroop, Shekhar
Vuyyuru, Sudheer Kumar
Kante, Bhaskar
Kumar, Peeyush
Mundhra, Sandeep Kumar
Arora, Umang
Goyal, Ankur
Kandasamy, Devasenathipathy
Sharma, Raju
Kabilan, Kavirajan
Kedia, Saurabh
Dash, Nihar Ranjan
Ahuja, Vineet
Funding for this research was provided by:
Stempeutics Research Pvt. Ltd, Bengaluru, Karnataka (SRPL/PAF/18-19/002)
Article History
Received: 11 November 2023
Accepted: 26 April 2024
First Online: 14 May 2024
Declarations
:
: The study was approved by Institutional ethics committees and institutional stem cell committee of All India Institute of Medical Sciences, New Delhi, India (Project title: An open-label, single-arm, investigator initiated phase I/II study to assess the safety and efficacy of local administration of stempeucel® (adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells) in patients with perianal fistulizing Crohn’s disease; Reference No: IC-SCR/94/19; date of approval: 6th May 2019).
: Audio-visual and written consent was taken from each patient for publication of all the information generated from the study.Audio-visual and written consent was taken for participation in the study from each patient.
: The authors have no financial disclosures or conflicts of interest to declare.